CD8A and lymphoma: Since immunization with NHP-B led to the induction of a CD8+ T-cell response and improved survival after lymphoma challenge, we analyzed if the frequency of NHP-B2-specific, SSPQGSPEPL-multimer-binding T-cells correlated with improved long-term survival.